Treatment Outcomes of AIDS-Associated Kaposi's Sarcoma under a Routine Antiretroviral Therapy Program in Lilongwe, Malawi: Bleomycin/Vincristine Compared to Vincristine Monotherapy.

Autor: Mwafongo, Albert A.¹ amwafongo@gmail.com, Rosenberg, Nora E.^1,2, Ng'ambi, Wingston³, Werner, Alexandra B.², Garneau, William M.², Gumulira, Joe³, Phiri, Sam³, Hosseinipour, Mina C.^1,2

Publikováno v: PLoS ONE. Mar2014, Vol. 9 Issue 3, p1-7. 7p.

RENAL EVENTS AMONG WOMEN TREATED WITH TENOFOVIR/EMTRICITABINE IN COMBINATION WITH EITHER LOPINAVIR/RITONAVIR OR NEVIRAPINE: ANALYSIS FROM THE AIDS CLINICAL TRIAL GROUP (ACTG) A5208 TRIAL

Autor: MWAFONGO, Albert, NKANAUNENA, Kondwani, ZHENG, Yu, HOGG, Evelyn, SAMANEKA, Wadzanai, MULENGA, Lloyd, SIIKA, Abraham, CURRIER, Judith, LOCKMAN, Shahin, HUGHES, Michael D., HOSSEINIPOUR, Mina

Tenofovir disoproxil fumarate (TDF) has been associated with renal insufficiency. Co-administration with boosted protease inhibitors, which increases its exposure, may further increase the risk of renal insufficiency.We compared the incidence of rena

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::4084be060f41bcb6bbe84eafb45e747f
https://europepmc.org/articles/PMC4176616/

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Treatment Outcomes of AIDS-Associated Kaposi's Sarcoma under a Routine Antiretroviral Therapy Program in Lilongwe, Malawi: Bleomycin/Vincristine Compared to Vincristine Monotherapy

Autor: Hosseinipour, Mina C., Werner, Alexandra B., Rosenberg, Nora E., Ng'ambi, Wingston, Garneau, William M., Phiri, Sam, Gumulira, Joe, Mwafongo, Albert A.

Despite Kaposi's sarcoma (KS) being the most prevalent AIDS-associated cancer in resource limited settings, optimal treatment options remain unknown. We assessed whether bleomycin/vincristine compared to vincristine monotherapy was associated with im

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d3b892b21cff49fffeaf64ef4ebb8750

Renal events among women treated with tenofovir/emtricitabine in combination with either lopinavir/ritonavir or nevirapine.

Autor: Mwafongo A; aUniversity of North Carolina Project, Kamuzu Central Hospital, Lilongwe bJohns Hopkins Project, Queen Elizabeth Central Hospital, Blantyre, Malawi cHarvard School of Public Health, Boston, Massachusetts dSocial & Scientific Systems, Inc., Silver Spring, Maryland, USA eUZ-UCSF Collaborative Research Programme, Harare, Zimbabwe fCenter for Infectious Disease Research, Lusaka, Zambia gMoi University (College of Health Sciences), Eldoret, Kenya hUniversity of California, Los Angeles, Los Angeles, California iBrigham and Women's Hospital, Boston, Massachusetts jUniversity of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA., Nkanaunena K, Zheng Y, Hogg E, Samaneka W, Mulenga L, Siika A, Currier J, Lockman S, Hughes MD, Hosseinipour M

Publikováno v: AIDS (London, England) [AIDS] 2014 May 15; Vol. 28 (8), pp. 1135-42.